Maruho Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maruho Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3301
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maruho Co Ltd (Maruho) carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers products for infectious disease, ear nose throat disorders, ophthalmology, musculoskeletal disorders, central nervous system (CNS) disorders, cardiovascular, gastrointestinal and other diseases. Maruho offers prescription drugs in various forms such as creams, ointments, lotions, tablets, injections, and gels. Its cosmeceutical products include soaps, shampoos and UV sunscreen, among others. The company operates facilities across Japan, as well as in Germany and the US. Maruho is headquartered in Osaka, Japan.

Maruho Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruho Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Cutanea Life Sciences Acquires US Rights for Xepi Cream from Medimetriks Pharma 10
Venture Financing 11
Dermira Raises US$35 Million In Series B Financing 11
Partnerships 13
Maruho and Galderma Pharma Enter into Agreement 13
Biofrontera Extends Its Agreement with Maruho 14
Licensing Agreements 15
Maruho Enters into Licensing Agreement with RaQualia Pharma 15
Maruho Enters into Licensing Agreement with 4SC 16
Maruho Enters into Licensing Agreement with Toray Industries 17
Maruho Enters into Licensing Agreement with Astellas Pharma 18
Maruho Enters into Licensing Agreement with Dermira for DRM04 19
Maruho Enters into Licensing Agreement with Astellas Pharma 20
Maruho Enters into Licensing Agreement with Chugai Pharma 21
Pierre Fabre Enters Into Licensing Agreement With Maruho For Infant Hemangiomas Treatment 22
Equity Offering 23
Biofrontera Completes Private Placement Of Shares For US$9.7 Million 23
Acquisition 24
Maruho Acquires Dermatology Company, Cutanea Life Sciences 24
Maruho Co Ltd – Key Competitors 25
Maruho Co Ltd – Key Employees 26
Maruho Co Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Maruho Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruho Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruho Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cutanea Life Sciences Acquires US Rights for Xepi Cream from Medimetriks Pharma 10
Dermira Raises US$35 Million In Series B Financing 11
Maruho and Galderma Pharma Enter into Agreement 13
Biofrontera Extends Its Agreement with Maruho 14
Maruho Enters into Licensing Agreement with RaQualia Pharma 15
Maruho Enters into Licensing Agreement with 4SC 16
Maruho Enters into Licensing Agreement with Toray Industries 17
Maruho Enters into Licensing Agreement with Astellas Pharma 18
Maruho Enters into Licensing Agreement with Dermira for DRM04 19
Maruho Enters into Licensing Agreement with Astellas Pharma 20
Maruho Enters into Licensing Agreement with Chugai Pharma 21
Pierre Fabre Enters Into Licensing Agreement With Maruho For Infant Hemangiomas Treatment 22
Biofrontera Completes Private Placement Of Shares For US$9.7 Million 23
Maruho Acquires Dermatology Company, Cutanea Life Sciences 24
Maruho Co Ltd, Key Competitors 25
Maruho Co Ltd, Key Employees 26
Maruho Co Ltd, Other Locations 28
Maruho Co Ltd, Subsidiaries 28

List of Figures
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maruho Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Maruho Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Olmsted Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care and clinical research services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes educati …
  • Willis Lease Finance Corp (WLFC)
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • MedStar Health:企業の戦略的SWOT分析
    MedStar Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Callon Petroleum Co (CPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of ne …
  • Peyto Exploration & Development Corp (PEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • BiosanaPharma BV:製薬・医療:M&Aディール及び事業提携情報
    Summary BiosanaPharma BV (Biosana) is a biotechnology company engaged in the development of monoclonal antibody biologicals (mAbs), biosimilars and biobetters. Its pipeline products include BP001: biosimilar of Omalizumab (anti-allergy); BP002: biosimilar of Denosumab (anti-osteoporosis); BOX001: or …
  • KDDI Corporation:企業の戦略・SWOT・財務情報
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Aramark Services Inc (ARMK):企業の財務・戦略的SWOT分析
    Aramark Services Inc (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CRH plc:企業のM&A・事業提携・投資動向
    CRH plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CRH plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務情報
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Insys Therapeutics Inc (INSY):製薬・医療:M&Aディール及び事業提携情報
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its flagship prod …
  • Exorka GmbH:企業の戦略的SWOT分析
    Exorka GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Epcor Utilities Inc:企業の戦略的SWOT分析
    Epcor Utilities Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • High Energy Batteries (India) Ltd
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Neuwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeuWave Medical Inc (NeuWave Medical), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. The company’s product Certus 140 microwave ablation (coagulation) system is a minimally invasive soft tissue abl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆